Antibody data
- Antibody Data
- Antigen structure
- References [25]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13126-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13126-1-AP, RRID:AB_2212761
- Product name
- USP24 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated USP24 antibody (Cat. #13126-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references USP24 inhibits autophagy in diabetic myocardial disorder by regulating TRAF6-mediated ubiquitination of Beclin-1.
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis.
ITCH regulates Golgi integrity and proteotoxicity in neurodegeneration.
Mettl1 knockdown alleviates cardiac I/R injury in mice by inactivating the Mettl1-CYLD-P53 positive feedback loop.
The deubiquitinase USP24 suppresses ferroptosis in triple-negative breast cancer by stabilizing DHODH protein.
Aberrant Notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma.
TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast cancer.
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1.
USP26 suppresses type I interferon signaling by targeting TRAF3 for deubiquitination.
NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cells.
USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2.
USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy.
USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase.
Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy.
Ubiquitin-specific protease 24 promotes EV71 infection by restricting K63-linked polyubiquitination of TBK1.
LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer.
USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway.
USP24 promotes drug resistance during cancer therapy.
USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy.
A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation.
The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability.
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP.
USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy.
Human Cytomegalovirus Protein pUL38 Prevents Premature Cell Death by Binding to Ubiquitin-Specific Protease 24 and Regulating Iron Metabolism.
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.
Wu S, Zhou Y, Shu M, Zhang H, Situ Q, Bao Z, Hu Z, Zhu J
Life sciences 2026 May 1;392:124296
Life sciences 2026 May 1;392:124296
LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis.
Bacchiocchi A, Mak M, Khan ZM, Gong X, Sznol M, Na Z, Su H, Chan LH, Yan Q, Zhao D, Mortlock RD, Knight J, Slavoff SA, Halaban R
Oncogene 2025 Oct;44(41):3974-3984
Oncogene 2025 Oct;44(41):3974-3984
ITCH regulates Golgi integrity and proteotoxicity in neurodegeneration.
Xiang Q, Lu Y, Wang H, Chen H, Chen P, Zhao X, Cortes Morales L, Yang Y, Yang J, Zhang T, Wang J
Science advances 2025 Oct 24;11(43):eado4330
Science advances 2025 Oct 24;11(43):eado4330
Mettl1 knockdown alleviates cardiac I/R injury in mice by inactivating the Mettl1-CYLD-P53 positive feedback loop.
Yu ST, Sun ZY, Li N, Qu ZZ, Wang CH, Ju TT, Liu YQ, Mei ZT, Liu KW, Lu MX, Huang M, Li Y, Dou SK, Jiang JH, Zhang YZ, Huang CH, Pang XC, Jia YQ, Dong XH, Wu F, Zhang Y, Li WH, Yang BF, Du WJ
Acta pharmacologica Sinica 2025 Mar;46(3):592-605
Acta pharmacologica Sinica 2025 Mar;46(3):592-605
The deubiquitinase USP24 suppresses ferroptosis in triple-negative breast cancer by stabilizing DHODH protein.
Yang L, An X, Yang S, Lin X, Chen Z, Xue Q, Chen X, Wang Y, Yan D, Chen S, Fan Y, Tang D, Yu W, Liu J, Chen X
Cell death & disease 2025 Jul 26;16(1):564
Cell death & disease 2025 Jul 26;16(1):564
Aberrant Notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma.
Li C, Wu P, Xie X, Chen X, Chen L, Zhu L, Xuan Z, Liu T, Tan W, Zhang S, Lin D, Wu C
Signal transduction and targeted therapy 2025 Jul 22;10(1):233
Signal transduction and targeted therapy 2025 Jul 22;10(1):233
TMEM45A enhances palbociclib resistance and cellular glycolysis by activating AKT/mTOR signaling pathway in HR+ breast cancer.
Chen C, Chen Z, Zhao J, Wen X, Yao H, Weng Z, Xiong H, Zheng Z, Wu J
Cell death discovery 2025 Feb 5;11(1):47
Cell death discovery 2025 Feb 5;11(1):47
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1.
Shan H, Yuan J, Xian L, Li W, Ge Y, Zhang L, Lin T, Lan M, Liu J, Luo Y, Wu Y, Xiao X
Cancer cell international 2025 Apr 26;25(1):164
Cancer cell international 2025 Apr 26;25(1):164
USP26 suppresses type I interferon signaling by targeting TRAF3 for deubiquitination.
Sheng CL, Jiang BD, Zhang CQ, Huang JH, Wang Z, Xu C
PloS one 2024;19(7):e0307776
PloS one 2024;19(7):e0307776
NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cells.
Wang SA, Wu YC, Yang FM, Hsu FL, Zhang K, Hung JJ
Molecular oncology 2024 Sep;18(9):2255-2276
Molecular oncology 2024 Sep;18(9):2255-2276
USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2.
Zhou N, Guo C, Li X, Tu L, Du J, Qian Q, Li J, Huang D, Xu Q, Zheng X
Biochemical pharmacology 2024 Nov;229:116473
Biochemical pharmacology 2024 Nov;229:116473
USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy.
Young MJ, Wang SA, Chen YC, Liu CY, Hsu KC, Tang SW, Tseng YL, Wang YC, Lin SM, Hung JJ
Cell death and differentiation 2024 May;31(5):574-591
Cell death and differentiation 2024 May;31(5):574-591
USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase.
Chen Y, Feng X, Wu Z, Yang Y, Rao X, Meng R, Zhang S, Dong X, Xu S, Wu G, Jie X
Journal of biomedical science 2024 May 28;31(1):55
Journal of biomedical science 2024 May 28;31(1):55
Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy.
Wu S, Zhou Y, Liang J, Ying P, Situ Q, Tan X, Zhu J
Free radical biology & medicine 2024 Jan;210:352-366
Free radical biology & medicine 2024 Jan;210:352-366
Ubiquitin-specific protease 24 promotes EV71 infection by restricting K63-linked polyubiquitination of TBK1.
Zang L, Gu J, Yang X, Yuan Y, Guo H, Zhou W, Ma J, Chen Y, Wu Y, Zheng H, Shi W
Virologica Sinica 2023 Feb;38(1):75-83
Virologica Sinica 2023 Feb;38(1):75-83
LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer.
Sun Z, Zhang R, Zhang X, Sun Y, Liu P, Francoeur N, Han L, Lam WY, Yi Z, Sebra R, Walsh M, Yu J, Zhang W
Molecular cancer 2022 Jul 16;21(1):147
Molecular cancer 2022 Jul 16;21(1):147
USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway.
He H, Yi L, Zhang B, Yan B, Xiao M, Ren J, Zi D, Zhu L, Zhong Z, Zhao X, Jin X, Xiong W
International journal of biological sciences 2021;17(10):2417-2429
International journal of biological sciences 2021;17(10):2417-2429
USP24 promotes drug resistance during cancer therapy.
Wang SA, Young MJ, Wang YC, Chen SH, Liu CY, Lo YA, Jen HH, Hsu KC, Hung JJ
Cell death and differentiation 2021 Sep;28(9):2690-2707
Cell death and differentiation 2021 Sep;28(9):2690-2707
USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy.
Wang SA, Young MJ, Jeng WY, Liu CY, Hung JJ
Scientific reports 2020 Nov 30;10(1):20870
Scientific reports 2020 Nov 30;10(1):20870
A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation.
Kim JM, Yang YS, Park KH, Ge X, Xu R, Li N, Song M, Chun H, Bok S, Charles JF, Filhol-Cochet O, Boldyreff B, Dinter T, Yu PB, Kon N, Gu W, Takarada T, Greenblatt MB, Shim JH
Nature communications 2020 May 8;11(1):2289
Nature communications 2020 May 8;11(1):2289
The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability.
Thayer JA, Awad O, Hegdekar N, Sarkar C, Tesfay H, Burt C, Zeng X, Feldman RA, Lipinski MM
Autophagy 2020 Jan;16(1):140-153
Autophagy 2020 Jan;16(1):140-153
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP.
Bufalieri F, Infante P, Bernardi F, Caimano M, Romania P, Moretti M, Lospinoso Severini L, Talbot J, Melaiu O, Tanori M, Di Magno L, Bellavia D, Capalbo C, Puget S, De Smaele E, Canettieri G, Guardavaccaro D, Busino L, Peschiaroli A, Pazzaglia S, Giannini G, Melino G, Locatelli F, Gulino A, Ayrault O, Fruci D, Di Marcotullio L
Nature communications 2019 Jul 24;10(1):3304
Nature communications 2019 Jul 24;10(1):3304
USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and β-TrCP and promotes cancer malignancy.
Wang YC, Wu YS, Hung CY, Wang SA, Young MJ, Hsu TI, Hung JJ
Nature communications 2018 Sep 28;9(1):3996
Nature communications 2018 Sep 28;9(1):3996
Human Cytomegalovirus Protein pUL38 Prevents Premature Cell Death by Binding to Ubiquitin-Specific Protease 24 and Regulating Iron Metabolism.
Sun Y, Bao Q, Xuan B, Xu W, Pan D, Li Q, Qian Z
Journal of virology 2018 Jul 1;92(13)
Journal of virology 2018 Jul 1;92(13)
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.
Engel K, Rudelius M, Slawska J, Jacobs L, Ahangarian Abhari B, Altmann B, Kurutz J, Rathakrishnan A, Fernández-Sáiz V, Brunner A, Targosz BS, Loewecke F, Gloeckner CJ, Ueffing M, Fulda S, Pfreundschuh M, Trümper L, Klapper W, Keller U, Jost PJ, Rosenwald A, Peschel C, Bassermann F
EMBO molecular medicine 2016 Aug;8(8):851-62
EMBO molecular medicine 2016 Aug;8(8):851-62
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- mouse lung tissue were subjected to SDS PAGE followed by western blot with 13126-1-AP(USP24 antibody) at dilution of 1:300
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of HepG2 cells, using USP24 antibody 13126-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line